It is becoming a lot simpler to obtain cannabis, legally. In the past two decades, almost half of the united states as well as the District of Columbia, have some form of a legal marijuana program. So have other countries, such as Finland, Germany, Spain, Israel and, Austria.
Supporters, like those who are interested in purchasing marijuana stocks, are in great belief that this has given many with intractable medical issues to obtain a safe and effective therapy. Opponents debate that these advantages are over exaggerated and that supporters do not pay attention to the dangers of cannabis. Mainly, opponents which state that the real mission is to obtain it for recreational reasons.
Both sides have valid reasons. Studies exist, yet, that can help give clarity to what we do and don’t know about medical marijuana.
A recent systematic analysis was published in the Journal of the American Medical Association which looked at all randomized controlled testing of marijuana or cannabinoids to treat medical issues. They discovered 79 trials involving more than 6,400 subjects. A majority of the testing did display signs of improvements in symptoms, yet most of those did not gain statistical value.
Medicinal cannabis was connected with truly impressive modifications in complete resolution of vomiting from nausea due to cancer therapy. It was shown to reduce pain levels by roughly half a point on a 10-point scale, and to lower spasticity in multiple sclerosis or paraplegia in a similar way.
Those are not results that should be overlooked and they are backed by other research that has been conducted which confirms that cannabis and cannabinoids can help with refractory discomfort due to pain, Yet the majority of researchers worry that they should be considered only when other treatments have not been successful.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
